A New World Through our Genes

The discoveries of the SCGC Paleo-Genetics Division

As one of the earliest genetic research corporations in the world, the Summerlee-Challenger Genetics Corporation has been at the forefront of gene related research for decades. In order to protect our ongoing experimentation, much of the work performed by the Paleo-Genetics Division is published by our business associates and partner scientific groups. This allows our organization to retain gained revenues and royalties while preserving anonymity.

Access to surviving paleontological specimens in Brazil allowed SCGC scientists to first extract and restore partial DNA from fossil tissue and amber encased mosquitoes. While our competitor International Genetics Technologies Corporation has publicly claimed this milestone and did succeed in cloning the first prehistoric species, our research contributed to their success and uses a more thorough process with more stable results compared to InGen’s shortcuts.

In addition to successful revival of extinct species, our labs have performed hundreds of experiments in pigmentation, post-development modification, disease, hybridization, intelligence and many other avenues of study.

Using our unique biological assets we have developed preliminary concepts for vaccine development, advanced our understanding of how cancers form and grow, and discovered chemical compounds which boost immune system function and improve cellular regeneration. We also continue to study how genetic markers can provide early warning of cognitive illness and post-development genetic modification can prevent or reverse damage. Our findings in Brazil and now on Isla Panadera can then be transferred to our more public research facilities in North America and Europe where comparative studies can be performed to ensure that our findings can also apply to mammals.

Through our hybridization research we have paved the way for advancements in Genetically Modified plants and animals since the 1970s. Our findings have lead to the development of hybrid and GM livestock and crops which are more productive, disease and insect resistant without any negative side effects. As we pursue additional developments in climate and drought tolerance these findings have and will continue to reduce world hunger.

In more commercial applications our findings may someday result in cosmetic gene therapy opportunities as an alternative to plastic surgery. New breeds of domesticated animals may be developed based on the addition or removal of individual traits and pigmentation. Some interest has been growing as well in the concept of miniaturized dinosaur clones as a future form of exotic pet.